目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS CONSIDERED AND REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.2.3 GROWTH FORECAST
2.2.4 CAGR PROJECTIONS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 GROWTH RATE ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 DIAGNOSTIC IMAGING MARKET OVERVIEW
4.2 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY REGION AND END USER, 2025
4.3 REGIONAL SNAPSHOT OF DIAGNOSTIC IMAGING MARKET

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population and the rising prevalence of associated diseases
5.2.1.2 Increasing demand for early diagnosis and widening scope of clinical applications
5.2.1.3 Technological advancements in diagnostic imaging modalities
5.2.1.4 Increasing investments, funds, and grants by public-private organizations
5.2.2 RESTRAINTS
5.2.2.1 High cost of diagnostic imaging systems
5.2.2.2 Technological limitations associated with standalone systems
5.2.2.3 Unfavorable reimbursement scenario
5.2.2.4 Shortage of helium
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies offer high growth potential
5.2.3.2 Adoption of AI and analytics in diagnostic imaging
5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers
5.2.3.4 Increasing adoption of teleradiology
5.2.3.5 Contract-based radiology solutions and mobile solutions
5.2.4 CHALLENGES
5.2.4.1 Hospital budget cuts
5.2.4.2 Increasing adoption of refurbished diagnostic imaging systems
5.2.4.3 Dearth of trained professionals
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT
5.4.2 MANUFACTURING & ASSEMBLY
5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALE SERVICES
5.5 ECOSYSTEM ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 BARGAINING POWER OF BUYERS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 THREAT OF NEW ENTRANTS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY LANDSCAPE
5.8.1 NORTH AMERICA
5.8.1.1 US
5.8.1.2 Canada
5.8.2 EUROPE
5.8.3 ASIA PACIFIC
5.8.3.1 Japan
5.8.3.2 China
5.8.3.3 India
5.9 TRENDS IMPACTING CUSTOMER BUSINESS
5.9.1 INCREASING ADOPTION OF HYBRID DIAGNOSTIC IMAGING MODALITIES
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGIES
5.10.1.1 Magnetic resonance imaging (MRI)
5.10.1.2 Computed tomography (CT)
5.10.1.3 Ultrasound imaging
5.10.2 COMPLEMENTARY TECHNOLOGIES
5.10.2.1 Picture archiving and communication systems (PACS)
5.10.2.2 Artificial intelligence (AI) for image analysis
5.10.2.3 Radiology information systems (RIS)
5.10.3 ADJACENT TECHNOLOGIES
5.10.3.1 Digital pathology
5.10.3.2 Molecular imaging/PET-CT
5.10.3.3 Wearable imaging sensors
5.11 REIMBURSEMENT SCENARIO
5.12 TRADE ANALYSIS
5.12.1 IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2020-2024 (USD THOUSAND)
5.12.2 EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2020-2024 (USD THOUSAND)
5.12.3 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS
5.12.3.1 Import data for ultrasound systems, by country, 2020-2024 (USD Thousand)
5.12.3.2 Export data for ultrasound systems, by country, 2020-2024 (USD Thousand)
5.12.4 TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS
5.12.4.1 Import data for magnetic resonance imaging systems, by country, 2020-2024 (USD Thousand)
5.12.4.2 Export data for magnetic resonance imaging systems, by country, 2020-2024 (USD Thousand)
5.12.5 TRADE ANALYSIS FOR X-RAY SYSTEMS
5.12.5.1 Import data for X-ray systems, by country, 2020-2024 (USD Thousand)
5.12.5.2 Export data for X-ray systems, by country, 2020-2024 (USD Thousand)
5.13 PATENT ANALYSIS
5.14 CASE STUDY ANALYSIS
5.15 KEY CONFERENCES AND EVENTS (2025-2026)
5.16 UNMET NEEDS
5.17 IMPACT OF AI ON DIAGNOSTIC IMAGING MARKET
5.17.1 INTRODUCTION
5.17.2 MARKET POTENTIAL OF AI IN DIAGNOSTIC IMAGING
5.17.3 AI USE CASES
5.17.4 KEY COMPANIES IMPLEMENTING AI
5.17.5 FUTURE OF GENERATIVE AI IN DIAGNOSTIC IMAGING
5.18 IMPACT OF 2025 US TARIFF
5.18.1 INTRODUCTION
5.18.2 KEY TARIFF RATES
5.18.3 PRICE IMPACT ANALYSIS
5.18.4 IMPACT ON COUNTRY/REGION
5.18.4.1 United States
5.18.4.2 Europe
5.18.4.3 Asia Pacific
5.18.5 IMPACT ON END-USE INDUSTRIES

6 DIAGNOSTIC IMAGING MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 X-RAY IMAGING SYSTEMS
6.2.1 GENERAL RADIOGRAPHY
6.2.1.1 Wide-scale application in chest imaging to drive market
6.2.2 DENTISTRY
6.2.2.1 High prevalence of dental disorders to drive market
6.2.3 FLUOROSCOPY
6.2.3.1 Rising use in gastrointestinal imaging to support market growth
6.3 MRI SYSTEMS
6.3.1 BRAIN & NEUROLOGICAL MRI
6.3.1.1 Rising incidence of neurodegenerative diseases to drive market
6.3.2 SPINE & MUSCULOSKELETAL MRI
6.3.2.1 Ability to diagnose musculoskeletal disorders to drive market
6.3.3 VASCULAR MRI
6.3.3.1 Adoption of AI to support market growth
6.3.4 PELVIC & ABDOMINAL MRI
6.3.4.1 Ability to detect prostate and cervical cancer to propel market
6.3.5 BREAST MRI
6.3.5.1 Growing awareness about early breast cancer screening to drive market
6.3.6 CARDIAC MRI
6.3.6.1 Rising incidence of CVD to support market growth
6.4 ULTRASOUND SYSTEMS
6.4.1 RADIOLOGY/GENERAL IMAGING
6.4.1.1 Extensive use in image-guided radiotherapy and radiology ultrasound to drive market
6.4.2 OBSTETRICS/GYNECOLOGY
6.4.2.1 Advancements in AI models for image guidance to support market growth
6.4.3 CARDIOLOGY
6.4.3.1 Rising prevalence of cardiovascular diseases to drive market
6.4.4 VASCULAR
6.4.4.1 Identification of vessel blockages and blot clots for early disease diagnosis to support market growth
6.4.5 UROLOGY
6.4.5.1 Growing awareness about therapeutic benefits of urological ultrasound to propel market
6.4.6 OTHER APPLICATIONS
6.5 CT SCANNERS
6.5.1 CARDIOLOGY
6.5.1.1 Rising incidence of obesity and hypertension to propel market
6.5.2 ONCOLOGY
6.5.2.1 Rising burden of cancer to drive market
6.5.3 NEUROLOGY
6.5.3.1 Increasing incidence of dementia and Alzheimer's to fuel market
6.5.4 OTHER APPLICATIONS
6.6 NUCLEAR IMAGING SYSTEMS
6.6.1 ONCOLOGY
6.6.1.1 Ability to distinguish between benign and malignant tumors to drive market
6.6.2 CARDIOLOGY
6.6.2.1 Rising incidence of coronary heart disease to support market
6.6.3 NEUROLOGY
6.6.3.1 Rising use of SPECT and PET systems for brain perfusion imaging to drive market
6.6.4 OTHER APPLICATIONS
6.7 MAMMOGRAPHY SYSTEMS
6.7.1 TECHNOLOGICAL ADVANCEMENTS IN MAMMOGRAPHY SYSTEMS TO SUPPORT MARKET GROWTH

7 DIAGNOSTIC IMAGING MARKET, BY MODALITY
7.1 INTRODUCTION
7.2 CT SCANNERS
7.2.1 CONVENTIONAL CT SCANNERS
7.2.1.1 High-slice CT scanners
7.2.1.1.1 High image resolution to drive market
7.2.1.2 Mid-slice CT scanners
7.2.1.2.1 Increasing affordability to propel market
7.2.1.3 Low-slice CT scanners
7.2.1.3.1 Low costs and rising adoption in emerging economies to drive market
7.2.2 CONE-BEAM CT SCANNERS
7.2.2.1 Growing applications in dental & ENT scanning to drive market
7.3 ULTRASOUND SYSTEMS
7.3.1 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY
7.3.2 2D ULTRASOUND SYSTEMS
7.3.2.1 Rise in demand for minimal invasive surgeries leading to increased use of 2D ultrasound
7.3.3 3D AND 4D ULTRASOUND
7.3.3.1 IMPROVED DIAGNOSIS WITH 3D ULTRASOUND TECHNOLOGY
7.3.4 DOPPLER ULTRASOUND
7.3.4.1 Growing application in cardiology and vascular to drive market growth
7.3.4.2 Contrast-enhanced ultrasound systems
7.3.4.2.1 Innovative product launches offering real-time monitoring capabilities to fuel market
7.3.5 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY
7.3.5.1 Trolley/Cart-based ultrasound systems
7.3.5.1.1 Utilization in pediatric and abdominal applications to propel market
7.3.5.2 Compact/Handheld ultrasound systems
7.3.5.2.1 High portability and user-friendly features to drive market
7.4 X-RAY IMAGING SYSTEMS
7.4.1 X-RAY IMAGING SYSTEMS MARKET, BY TYPE
7.4.1.1 Digital X-ray imaging systems
7.4.1.2 Analog X-ray imaging systems
7.4.1.2.1 High risk of radiation exposure and limitations to impede market growth
7.4.2 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY
7.4.2.1 Stationary X-ray imaging systems
7.4.2.1.1 Efficient configuration integration in diagnostic clinics to propel market
7.4.2.2 Portable X-ray imaging systems
7.4.2.2.1 Rising use in trauma care and emergency departments to boost adoption
7.5 MRI SYSTEMS
7.5.1 MRI SYSTEMS MARKET, BY ARCHITECTURE
7.5.1.1 Closed MRI systems
7.5.1.1.1 Reduced examination time and improved image quality to drive market
7.5.1.2 Open MRI systems
7.5.1.2.1 High patient comfort to boost adoption
7.5.2 MRI SYSTEMS MARKET, BY FIELD STRENGTH
7.5.2.1 High and very-high-field MRI systems
7.5.2.1.1 High safety & image resolution to drive market
7.5.2.2 Low-to-mid-field MRI systems
7.5.2.2.1 Technological limitations to restrain market
7.5.2.3 Ultra-high-field MRI systems
7.5.2.3.1 High utilization in musculoskeletal & neurological applications to support market growth
7.6 NUCLEAR IMAGING SYSTEMS
7.6.1 SPECT SYSTEMS
7.6.2 PET SYSTEMS
7.6.3 HYBRID SPECT SYSTEMS
7.6.3.1 Enhanced resolution to support market growth
7.7 MAMMOGRAPHY SYSTEMS
7.7.1 RISING AWARENESS ABOUT BREAST CANCER TO SUPPORT MARKET GROWTH

8 DIAGNOSTIC IMAGING MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 INCREASED NUMBER OF MRI, PET, CT SCANS TO PROPEL DIAGNOSTIC IMAGING MARKET
8.3 DIAGNOSTIC IMAGING CENTERS
8.3.1 RISING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO FUEL MARKET
8.4 OTHER END USERS

9 DIAGNOSTIC IMAGING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
9.2.2 US
9.2.2.1 High incidence of chronic diseases to drive market
9.2.3 CANADA
9.2.3.1 Rising cases of chronic disease to support market growth
9.3 ASIA PACIFIC
9.3.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
9.3.2 JAPAN
9.3.2.1 Presence of universal healthcare coverage to fuel market
9.3.3 CHINA
9.3.3.1 Government initiatives for establishment of hospitals to drive market
9.3.4 INDIA
9.3.4.1 Improvements in healthcare infrastructure and rising incidence of CVD to drive market
9.3.5 SOUTH KOREA
9.3.5.1 Growing access to advanced ultrasound systems to support market growth
9.3.6 AUSTRALIA
9.3.6.1 Increasing healthcare spending to propel market
9.3.7 REST OF ASIA PACIFIC
9.4 EUROPE
9.4.1 EUROPE: MACROECONOMIC OUTLOOK
9.4.2 GERMANY
9.4.2.1 High number of MRI units to drive the market
9.4.3 UK
9.4.3.1 Increasing investments in diagnostic imaging to drive market
9.4.4 ITALY
9.4.4.1 Established healthcare infrastructure to support market growth
9.4.5 SPAIN
9.4.5.1 Growing access to advanced cancer diagnostics to propel market
9.4.6 REST OF EUROPE
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
9.5.2 BRAZIL
9.5.2.1 High export of medical devices to propel market
9.5.3 MEXICO
9.5.3.1 Rising R&D initiatives on oncology imaging to support market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
9.6.2 GCC COUNTRIES
9.6.2.1 Integration of AI to support market growth
9.6.3 REST OF MIDDLE EAST & AFRICA
9.6.3.1 Advancements in healthcare sector to support market growth

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
10.3 REVENUE ANALYSIS, 2022-2024
10.4 MARKET SHARE ANALYSIS
10.5 RANKING OF KEY PLAYERS, 2024
10.6 COMPANY VALUATION AND FINANCIAL METRICS
10.7 BRAND/PRODUCT COMPARISON
10.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.8.1 STARS
10.8.2 PERVASIVE PLAYERS
10.8.3 EMERGING LEADERS
10.8.4 PARTICIPANTS
10.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.8.5.1 Company footprint
10.8.5.2 Modality footprint
10.8.5.3 Application footprint
10.8.5.4 End user footprint
10.8.5.5 Region footprint
10.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.9.1 PROGRESSIVE COMPANIES
10.9.2 RESPONSIVE COMPANIES
10.9.3 DYNAMIC COMPANIES
10.9.4 STARTING BLOCKS
10.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
10.9.5.1 Detailed list of key startups/SMEs
10.9.5.2 Competitive benchmarking of key startups/SMEs
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES AND APPROVALS
10.10.2 DEALS
10.10.3 EXPANSIONS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 SIEMENS HEALTHINEERS
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches, upgrades, and approvals
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Key strengths
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 GE HEALTHCARE
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches, upgrades, and approvals
11.1.2.3.2 Deals
11.1.2.3.3 Expansions
11.1.2.3.4 Other developments
11.1.2.4 MnM view
11.1.2.4.1 Key strengths
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses and competitive threats
11.1.3 KONINKLIJKE PHILIPS N.V.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches, upgrades, and approvals
11.1.3.3.2 Deals
11.1.3.3.3 Expansions
11.1.3.4 MnM view
11.1.3.4.1 Key strengths
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses and competitive threats
11.1.4 FUJIFILM CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product launches, upgrades, and approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats.
11.1.5 CANON
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product launches, upgrades, and approvals
11.1.5.3.2 Deals
11.1.5.3.3 Expansions
11.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches, upgrades, and approvals
11.1.6.3.2 Deals
11.1.7 ESAOTE S.P.A
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.7.3.1 Product launches, upgrades, and approvals
11.1.7.3.2 Deals
11.1.8 SAMSUNG HEALTHCARE
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches, upgrades, and approvals
11.1.8.3.2 Deals
11.1.8.3.3 Other developments
11.1.9 SHIMADZU CORPORATION
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Product launches, upgrades, and approvals
11.1.9.3.2 Deals
11.1.10 CARESTREAM HEALTH
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Product launches, upgrades, and approvals
11.1.10.3.2 Deals
11.1.11 PLANMED OY
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 HOLOGIC, INC.
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.12.3.1 Deals
11.1.13 AGFA-GEVAERT GROUP
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.14 CURVEBEAM AI, LTD.
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.14.3.1 Deals
11.1.15 UNITED IMAGING HEALTHCARE CO., LTD.
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.1.15.3.1 Product launches, upgrades, and approvals
11.1.15.3.2 Deals
11.1.15.3.3 Expansions
11.2 OTHER PLAYERS
11.2.1 ALLENGERS MEDICAL SYSTEMS LTD.
11.2.2 ANALOGIC CORPORATION
11.2.3 ASPECT IMAGING LTD.
11.2.4 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.
11.2.5 CHISON MEDICAL TECHNOLOGIES CO., LTD.
11.2.6 KONICA MINOLTA, INC.
11.2.7 MEDGYN PRODUCTS, INC.
11.2.8 NEUSOFT MEDICAL SYSTEMS CO., LTD.
11.2.9 PROMED TECHNOLOGY CO., LTD.
11.2.10 CMR NAVISCAN
11.2.11 CLARIUS
11.2.12 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
11.2.13 SHENZHEN ANKE HIGH-TECH., LTD.
11.2.14 STERNMED GMBH
11.2.15 TIME MEDICAL SYSTEMS

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS